Carbamazepine vs Durvalumab

Carbamazepine vs Durvalumab: Overview

This comparison examines the pharmacological differences between Carbamazepine and Durvalumab.

Mechanism of Action

Carbamazepine: Voltage-gated sodium channel blocker.

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Pharmacokinetics

Half-life: Carbamazepine — 25-65 hours; Durvalumab — 17 days.

Chemical Properties

Molecular Formula: Carbamazepine — C15H12N2O.

Molecular Weight: Carbamazepine — 236.2690 g/mol.

Type: Carbamazepine — Small molecule; Durvalumab — Antibody.